{
      "brief_title": [
            "study",
            "aripiprazole",
            "patient",
            "major",
            "depressive",
            "disorder"
      ],
      "brief_summary": [
            "trial",
            "safety",
            "study",
            "evaluate",
            "safety",
            "adjunctive",
            "aripiprazole",
            "outpatient",
            "major",
            "depressive",
            "disorder",
            "experience",
            "incomplete",
            "response",
            "ongoing",
            "antidepressant",
            "trial"
      ],
      "condition": [
            "major",
            "depressive",
            "disorder"
      ],
      "intervention_type": [
            "drug"
      ],
      "intervention_name": [
            "antidepressant",
            "aripiprazole"
      ],
      "description": [
            "antidepressant",
            "aripiprazole",
            "tablet",
            "oral",
            "aripiprazole",
            "daily"
      ],
      "arm_group_label": [
            "antidepressant",
            "aripiprazole"
      ],
      "other_name": [
            "abilify"
      ],
      "criteria": [
            "inclusion",
            "criterion",
            "men",
            "woman",
            "18",
            "year",
            "older",
            "experience",
            "major",
            "depressive",
            "disorder",
            "duration",
            "minimally",
            "8",
            "week",
            "treatment",
            "history",
            "inadequate",
            "response",
            "least",
            "one",
            "four",
            "antidepressant"
      ],
      "gender": [],
      "minimum_age": [
            "18",
            "year"
      ],
      "maximum_age": [],
      "healthy_volunteers": false,
      "id": "NCT00095745.xml"
}